COCP logo

Cocrystal Pharma (COCP) Company Overview

Profile

Full Name:

Cocrystal Pharma, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 22, 2012

Indexes:

Not included

Description:

Cocrystal Pharma is a biotechnology company focused on developing innovative antiviral and cancer treatments. They use a unique approach called cocrystal technology to create new medicines that can improve patient outcomes and address unmet medical needs in various diseases.

Events Calendar

Earnings

Next earnings date:

May 13, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 29, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 11, 2022

Analyst ratings

Recent major analysts updates

Jan 22, 25 HC Wainwright & Co.
Buy
May 14, 24 HC Wainwright & Co.
Buy
Apr 4, 24 HC Wainwright & Co.
Buy
Mar 20, 24 HC Wainwright & Co.
Buy
Jan 3, 24 HC Wainwright & Co.
Buy
Dec 4, 23 HC Wainwright & Co.
Buy
Oct 4, 23 HC Wainwright & Co.
Buy
Aug 15, 23 HC Wainwright & Co.
Buy
Aug 11, 23 HC Wainwright & Co.
Buy
Jun 2, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344
Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344
Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344
COCP
globenewswire.comDecember 31, 2024

BOTHELL, Wash., Dec. 31, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces plans to extend enrollment in the Phase 2a human challenge study with its investigational, broad-spectrum, oral influenza PB2 inhibitor CDI-42344 due to unexpectedly low influenza infection among study participants who were challenged with a H3N2 viral strain. This randomized, double-blind, placebo-controlled Phase 2a study is evaluating the safety, tolerability, pharmacokinetics (PK), antiviral activity and clinical measurements of CC-42344 at a single site in the United Kingdom.

Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences
Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences
Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences
COCP
globenewswire.comAugust 19, 2024

BOTHELL, Wash., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc .'s (Nasdaq: COCP) management announces its participation in the upcoming Virtual Investor Summit Microcap Forum in August and the H.C. Wainwright 26th Annual Global Investment Conference in September.

CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event
CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event
CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event
COCP
accesswire.comAugust 15, 2024

NEW YORK, NY / ACCESSWIRE / August 15, 2024 / CoCrystal Pharma (NASDAQ:COCP), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses and noroviruses, announces that management will present a company overview at the virtual Investor Summit Microcap Forum being held Tuesday, August 20, 2024. Management will be available for 1-on-1 meetings throughout the day.

Penny Stocks To Buy Now? 4 Under $3 To Watch This Week
Penny Stocks To Buy Now? 4 Under $3 To Watch This Week
Penny Stocks To Buy Now? 4 Under $3 To Watch This Week
COCP
PennyStocksApril 10, 2023

Penny stocks to watch this week under $3. The post Penny Stocks To Buy Now?

FAQ

  • What is the ticker symbol for Cocrystal Pharma?
  • Does Cocrystal Pharma pay dividends?
  • What sector is Cocrystal Pharma in?
  • What industry is Cocrystal Pharma in?
  • What country is Cocrystal Pharma based in?
  • When did Cocrystal Pharma go public?
  • Is Cocrystal Pharma in the S&P 500?
  • Is Cocrystal Pharma in the NASDAQ 100?
  • Is Cocrystal Pharma in the Dow Jones?
  • When was Cocrystal Pharma's last earnings report?
  • When does Cocrystal Pharma report earnings?
  • Should I buy Cocrystal Pharma stock now?

What is the ticker symbol for Cocrystal Pharma?

The ticker symbol for Cocrystal Pharma is NASDAQ:COCP

Does Cocrystal Pharma pay dividends?

No, Cocrystal Pharma does not pay dividends

What sector is Cocrystal Pharma in?

Cocrystal Pharma is in the Healthcare sector

What industry is Cocrystal Pharma in?

Cocrystal Pharma is in the Biotechnology industry

What country is Cocrystal Pharma based in?

Cocrystal Pharma is headquartered in United States

When did Cocrystal Pharma go public?

Cocrystal Pharma's initial public offering (IPO) was on February 22, 2012

Is Cocrystal Pharma in the S&P 500?

No, Cocrystal Pharma is not included in the S&P 500 index

Is Cocrystal Pharma in the NASDAQ 100?

No, Cocrystal Pharma is not included in the NASDAQ 100 index

Is Cocrystal Pharma in the Dow Jones?

No, Cocrystal Pharma is not included in the Dow Jones index

When was Cocrystal Pharma's last earnings report?

Cocrystal Pharma's most recent earnings report was on Nov 13, 2024

When does Cocrystal Pharma report earnings?

The next expected earnings date for Cocrystal Pharma is May 13, 2025

Should I buy Cocrystal Pharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions